Categories
Uncategorized

Global Non-alcoholic Steatohepatitis (NASH) Treatment Market 2020 Global Analysis, Segments, Size, Share, Industry Growth and Recent Trends by Forecast to 2026

The global non-alcoholic steatohepatitis (NASH) treatment market size is projected to gain impetus from a rise in the incidence of diabetes. This information is provided in an upcoming report by Fortune Business Insights, titled, “Non-alcoholic Steatohepatitis Treatment Market Size, Share and Global Trend By Drug Class (PPAR agonists, FXR-bile acid axis, Anti-oxidants, GLP-1/DPP-4/SGLT-2 agent, Anti-inflammatory agents, Anti-fibrotic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026.”

Segmentation of the Non-alcoholic Steatohepatitis (NASH) Treatment Market

By Drug Class            

  • PPAR agonists
  • FXR-bile acid axis
  • Anti-oxidants
  • GLP-1/DPP-4/SGLT-2 agent
  • Anti-inflammatory agents
  • Anti-fibrotic
  • Others

By Distribution Channel      

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography           

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

 

 

More Trending Topics From Fortune Business [email protected]

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market

Surgical Sutures Market